An Open Label Trial to Evaluate Efficacy and Safety of Roflumilast 0.3% Cream for Chronic Plaque and Nail Psoriasis
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- Modern Research Associates, PLLC
- Study ID
- NCT07725822
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Chronic Plaque and Nail Plate Psoriasis
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Roflumilast 0.3% topical cream — DRUGRoflumilast 0.3% topical cream QD
Study Details
This is an open label trial in subjects ≥12 years of age and older with chronic plaque psoriasis and moderate to severe nail psoriasis. Eligible participants will apply roflumilast 0.3% cream daily for 24 weeks to affected nails daily for the entire study duration and to psoriasis plaques daily until clear.
Key Dates
- First listed
- Jul 24, 2026
- Start date
- Aug 31, 2026
- Status verified
- Jul 2026
- Primary completion
- Jul 31, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 15 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Roflumilast 0.3% topical cream
Primary Outcome Measure
Mean Change in NAPSI [ Time Frame: 24 weeks ]
Central Contacts
- Stacy Reed214-361-2008
- Melodie Young, NP214-361-2008
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Modern Research Associates, PLLC | Dallas | Texas | 75231 | Melodie Young, MSN, A/GNP (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Dallas, TX
By research site